vTv Therapeutics Company Profile, Contacts & Intelligence

Pharmaceutical Manufacturing3980 Premier Dr52 employees
2 contacts with email or phone data2 with email data1 with phone data
View verified contacts Compare competitors
Employees
52
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts
Departments
3
Mapped contact coverage

vTv Therapeutics Overview

vTv Therapeutics is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. vTv’s clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential first-in-class oral glucokinase activator being investigated for the treatment of type 1 diabetes. vTv and its development partners are investigating multiple molecules for different chronic diseases. Cadisegliatin is under investigation and the safety and efficacy have not been established. There is no guarantee that this product will receive health authority approval or become commercially available for the use being investigated.

Headquarters
3980 Premier Dr
Website
vtvtherapeutics.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
Type 1 Diabetes and T1D

vTv Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data and 1 with phone data in the visible sample.
3 departments represented
Visible contacts with email or phone data are mapped to these departments.
5 company-domain emails
Visible contacts using vTv Therapeutics's company email domain.
General
3
Executive
2
Healthcare
1

vTv Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

R
Rich Nelson
Executive Vice President - Corporate
EP
K
Kadum Al Shareffi
Principle Research Scientist at Pfizer
E
T
Thomas Soeder
Vice President, Biometrics at Vtv
P
Paul Sekhri

vTv Therapeutics Workforce Composition

Seniority breakdown across 13 visible profiles.

Individual contributor
6
Executive
3
Director
2
VP / Head
1
Senior / Lead
1

Compare Similar Companies to vTv Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Paratek Pharmaceuticals Pharmaceutical Manufacturing 350 View company
Arbor Biotechnologies Biotechnology Research 114 View company
CARGO Therapeutics Biotechnology Research 87 View company
Latigo Biotherapeutics, Inc. Biotechnology Research 44 View company
Black Diamond Therapeutics Biotechnology Research 35 View company
Plus Therapeutics, Inc. Pharmaceutical Manufacturing 24 View company
Araris Biotech AG Biotechnology Research 20 View company
EsoBiotec Biotechnology Research 15 View company
AzurBio Consulting Business Consulting And Services 13 View company
AzurBio Pharma Biotechnology Research 11 View company